Slide 1: Dexcom earnings presentation
bpexcom ; y l a Nt if iu ai Dexcom earnings | dees
Slide 2: Safe harbor statement
Safe harbor statement This presentation contains “forward-looking statements" that are based on our management's beliefs and assumptions and on information available to management as of July 25, 2024. We intend for such forward-looking statements to be covered by the safe harbor provisions for forwa
Slide 3: Second quarter 2024 highlights
Second quarter 2024 iil Key Financial Strategic $1.004 billion in revenue Highlights Highlights 16% organic revenue! growth over Q2'23, Operating margin of 19.5%, up 130 bps Launched direct-to-watch feature for (19% US; 10% INT'L2) over Q2'23, and Adjusted EBITDA margin* of 28.3%, up 160 bps over Q2
Slide 4: Second quarter performance
Second quarter performance Total Revenue & Organic Growth Rate”! ($mm) 1,200 $300 $871 $975 $1,035 $921 $1,004 $800 $600 $400 $200 | [Ewag +26% +26% +25% +16% $0 a223 @3'23 Q4'23 ar24 a224 Non-GAAP Operating Margin* 4 38 24.5% 23.5% 30% | 18.2% 15.2% 19.5% 15% 10% 5% 0% Q2'23 Q3'23 Q4'23 Qv24 Q2'24
Slide 5: 2024 Guidance as of July 25, 2024
2024 Guidance as of July 25, 2024 2024 Annual Revenue and Profitability Guidance Non-GAAP Non-GAAP Adjusted Revenue Gross Profit Margin* Operating Margin* EBITDA Margin*! . USD Previous ~/, 200-4350 ~63-64% ~20% ~29% billion USD Updated ~44.000-4.050 ~63% ~20% ~29% billion 1 Adjusted EBITDA is defin
Slide 6: Appendix: Revenue Data and GAAP Reconciliations
bexcom Appendix Revenue Data and GAAP Reconciliations
Slide 7: GAAP to non-GAAP reconciliation
Three Months Ended June 30, Three Months Ended June 30, (In millions) 2024 2023 (In millions, except per share data) 2024 2023 GAAP gross profit $ 626.7 $ 546.4 GAAP net income $ 143.5 $ 115.9 Amortization of intangible assets (1) 7.1 7.1 Amortization of intangible assets (1) 8.4 8.8 Business transi
Slide 8: Revenue Metrics By Component
Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 YTD' 22 YTD' 23 YTD' 24 Revenue Metrics By Component Sensor & Other Revenue (millions) (1) (2) $ 543.2 $ 597.7 $ 666.6 $ 714.8 $ 651.9 $ 778.0 $ 873.8 $ 947.0 $ 854.3 $ 947.0 $ 1,140.9 $ 1,429.9 $ 1,801.3 Year over year growth 28% 21% 22% 1
Slide 9: Revenue Metrics By Geography
Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 YTD' 22 YTD' 23 YTD' 24 Revenue Metrics By Geography US Revenue (millions) $ 451.2 $ 511.0 $ 573.4 $ 606.4 $ 526.0 $ 616.6 $ 713.6 $ 769.1 $ 653.2 $ 731.9 $ 962.2 $ 1,142.6 $ 1,385.1 Year over year growth 18% 11% 17% 17% 17% 21% 24% 27% 24%
Slide 10: Organic Revenue reconciliation
Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 YTD' 22 YTD' 23 YTD' 24 (1) Organic Revenue INT'L Revenue - Reported $ 177.6 $ 185.2 $ 196.2 $ 208.8 $ 215.5 $ 254.7 $ 261.4 $ 265.4 $ 267.8 $ 272.4 $ 362.8 $ 470.2 $ 540.2 Impact of Acquired Revenue (6.4) (9.0) (3.0) 0.0 0.0 0.0 0.0 0.0 0.
Slide 11: Non-GAAP adjustment definitions
DexCom, Inc. Amortization of intangible assets - We are required under GAAP to record the fair values of the intangible assets of the entity on our balance sheet and amortize them over their useful lives. We exclude these non-cash amortization charges related to acquired intangible assets from our n